Dr. Mena is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
301 S Fair Oaks Ave
Ste 405
Pasadena, CA 91105Phone+1 626-440-7325Fax+1 626-440-7310
Education & Training
Adventist Health White MemorialResidency, Internal Medicine, 1999 - 2002
Keck School of Medicine of the University of Southern CaliforniaClass of 1999
Certifications & Licensure
CA State Medical License 2000 - 2026- National Board of Physicians and Surgeons Internal Medicine
Clinical Trials
- Placebo Controlled Study Using Lovaza as Treatment for Non-Alcoholic Fatty Liver Disease Start of enrollment: 2009 Sep 01
- Direct Acting Antiviral-Post Authorization Safety Study Start of enrollment: 2018 Mar 09
Publications & Presentations
PubMed
- 11 citationsPractical strategies for pruritus management in the obeticholic acid-treated patient with PBC: proceedings from the 2018 expert panel.Jennifer Pate, Juilo A Gutierrez, Catherine Frenette, Aparna Goel, Sonal Kumar
BMJ Open Gastroenterology. 2019-02-01 - 48 citationsFatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals.Mazen Noureddin, Micaela M Wong, Tsuyoshi Todo, Shelly C. Lu, Arun J. Sanyal
World Journal of Gastroenterology. 2018-03-21 - 14 citationsAdherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy.Steven-Huy B. Han, Wuhua Jing, Edward Mena, Michael Li, Brett Pinsky
Journal of Medical Economics. 2012-07-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
